Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

FFA's causes may include environmental triggers and genetic factors.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Doctors need to be better prepared to assess and treat obesity in patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.